Fahey Sandell Jacquelyn
SEC CIK 1984647 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics, Inc. | CLO | 123.1K | — | $54.3K | 5 | 2023-10-01 | 2025-02-21 |
Most active insiders at VYGR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sandrock Alfred | Pres, CEO, Dir | — | $184.4K |
| 2 | Swartz Robin | COO, CBO | — | $55.3K |
| 3 | Jorgensen Nathan D. | CFO | — | $54.2K |
| 4 | Carter Todd Alfred | CSO | — | $40.6K |
| 5 | Shiferman Gregory L. | SVP, GC | — | — |
| 6 | Ferguson Toby | Chief Medical Off | — | — |
Fahey Sandell Jacquelyn made no open-market trades at VYGR in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-24 | 2025-02-21 | VYGR | Voyager Therapeutics, Inc. | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +41.5K | 123.1K | +51% | $0 |
| 2025-02-12 | 2025-02-11 | VYGR | Voyager Therapeutics, Inc. | Fahey Sandell Jacquelyn | CLO | S - Sale | $4.45 | -4,358 | 81.6K | -5% | -$19.4K | |
| 2024-10-03 | 2024-10-02 | VYGR | Voyager Therapeutics, Inc. | Fahey Sandell Jacquelyn | CLO | S - Sale | $5.82 | -5,999 | 86.0K | -7% | -$34.9K | |
| D | 2024-02-16 | 2024-02-09 | VYGR | Voyager Therapeutics, Inc. | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +31.0K | 92.0K | +51% | $0 |
| 2023-10-02 | 2023-10-01 | VYGR | Voyager Therapeutics, Inc. | Fahey Sandell Jacquelyn | CLO | A - Grant | $0.00 | +61.0K | 61.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations